Stockreport

TriSalus Reports Q2 2024 Financial Results and Business Update

TriSalus Life Sciences, Inc.  (TLSI) 
PDF Reported revenues of $7.4 million in Q2 2024 and $13.8 million for six months ended June 30, 2024, up 60% and 82%, respectively, compared to prior year periodsReported g [Read more]